Sponsored by:

Molecular Imaging: Page 110

PET/CT with Ga-68 tracer better for cancer patients
By Wayne Forrest
By attaching gallium-68 (Ga-68) to a fibroblast activation protein molecule inhibitor, German researchers have achieved greater accuracy with PET/CT in staging patients with pancreatic ductal adenocarcinoma, according to a study published online October 23 in the Journal of Nuclear Medicine.
November 1, 2020
2020 10 29 22 40 7384 2020 11 02 Ga68 Fapi Pet Ct Pdac Jnm 400
Doc proposes virtual autopsy for coroner's office
By AuntMinnie.com staff writers
A nuclear medicine physician running for county coroner in Ohio is proposing that if he wins the office, he will adopt virtual autopsy as a method for investigating deaths in the county, according to a local newspaper.
October 29, 2020
2020 10 29 23 08 3417 Human Body Xray 400
Emerging PET tracer excels at tau pathology, differentiates dementias
By Emily Hayes
A new PET radiotracer for tau pathologies is showing promise for helping diagnose and differentiate Alzheimer's disease from a wide range of other dementia disorders. Researchers detailed their early experiences in animal and patient studies in Neuron online October 29.
October 28, 2020
2020 10 28 23 41 9514 2020 10 29 Tau Protein Ad Spectrum 20201028231743
Aprinoia gets approval for PET tracer trial in China
By AuntMinnie.com staff writers
Neuroscience biopharmaceutical company Aprinoia Therapeutics has announced that the China National Medical Products Administration has approved the company's phase III clinical trial of its PET imaging tracer.
October 27, 2020
2019 07 17 22 41 3854 Brain Puzzle Dementia 400
Use F-18 fluciclovine PET/MRI to stage prostate cancer
By Kate Madden Yee
PET/MRI with the F-18 fluciclovine radiotracer shows promise for initial staging of high-risk prostate cancer and for evaluating response to androgen deprivation therapy, according to a pilot study published online October 14 in the American Journal of Roentgenology.
October 27, 2020
2020 10 27 20 13 5656 2020 10 27 Ajr Pet Mri 20201027203041
PSMA-PET reveals new salivary glands
By Melissa Busch
Imaging with the use of prostate-specific membrane antigen (PSMA) has led to the discovery of a pair of salivary glands, found tucked away inside the skull where the nasal cavity and throat meet. The findings were published recently in Radiotherapy & Oncology.
October 27, 2020
2020 10 27 18 58 4429 2020 10 27 Salivary Glands 1 20201027183608
SNNMI joins doc groups criticizing 'COVID-19 inflation' theory
By AuntMinnie.com staff writers
A wide range of physician groups -- including the Society of Nuclear Medicine and Molecular Imaging (SNMMI) -- are criticizing statements made by President Donald Trump recently that physicians are inflating the number of deaths from COVID-19 for financial gain.
October 26, 2020
2018 05 22 18 57 9927 Snmmi Logo 400
PET with Axumin boosts prostate cancer outcomes
By Emily Hayes
Patients with recurrent prostate cancer had better outcomes when PET with the Axumin radiopharmaceutical was part of the imaging package guiding their radiation therapy, according to a study presented on October 26 at the American Society for Radiation Oncology annual meeting.
October 26, 2020
2019 09 16 03 57 7061 Astro 2019 400
Radiomics can aid management of lung cancer patients
By Erik L. Ridley
Researchers from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL, have reported that CT radiomics features can help predict tumor behavior in screening-detected lung cancer. They've also found that PET/CT radiomics shows promise for guiding non-small cell lung cancer treatment decisions.
October 25, 2020
2020 09 08 22 00 6800 Lung Cancer2 400
MGH researchers validate PET tracer for brain injury
By AuntMinnie.com staff writers
Researchers from Massachusetts General Hospital (MGH) have validated a new radiolabeled molecule that can be used with imaging tests to accurately detect and characterize brain injury. The U.S. Food and Drug Administration recently cleared the study team, led by Nicolas Guehl, PhD, an investigator in the department of radiology at MGH, to begin a first-in-human study.
October 22, 2020
2018 07 24 00 33 7964 Brain 400
FDA clears cyclotron Ga-68 DOTATOC production process
By AuntMinnie.com staff writers
The University of Iowa in Iowa City has received clearance from the U.S. Food and Drug Administration (FDA) for a new process for producing via cyclotron the investigational radiopharmaceutical gallium-68 (Ga-68) DOTATOC for localizing neuroendocrine tumors.
October 21, 2020
2020 10 22 22 52 2553 Fda Drugs Approval 400
QC failure halts Mo-99 supply in Australia
By AuntMinnie.com staff writers
The failure of a batch of molybdenum-99 (Mo-99) to pass a quality control (QC) inspection has caused an interruption in nuclear medicine procedures in Australia, according to an article published October 21 in the Guardian.
October 20, 2020
2018 07 20 22 27 4483 Australian Flag 400
Previous Page
Page 110 of 614
Next Page